FLUOXETINE HYDROCHLORIDE (fluoxetine) by Charter Medical is unknown, it is presumed to be linked to its inhibition of cns neuronal uptake of serotonin. Approved for premenstrual dysphoric disorder (pmdd) ( ) 1, premenstrual dysphoric disorder (pmdd) [see clinical studies ()]. First approved in 2016.
Drug data last refreshed 20h ago
unknown, it is presumed to be linked to its inhibition of CNS neuronal uptake of serotonin.
Fluoxetine and Understanding Social Experiences
Fluoxetine on Emotional Experience (FLEX) Study
Department of Defense PTSD Adaptive Platform Trial - Intervention A - Fluoxetine
Fluoxetine vs CBT in Childhood Anxiety Disorders
Study on the Optimal Strategy of Chinese Patients With Bulimia Nervosa After Fluoxetine Treatment
Worked on FLUOXETINE HYDROCHLORIDE at Charter Medical? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.